COVID-19 Impact on Global Cell-Free Fetal DNA Testing Market Size, Status and Forecast 2020-2026

September 2020 | 95 pages | ID: C4DB723F1177EN
QYResearch

Abstracts

This report focuses on the global Cell-Free Fetal DNA Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell-Free Fetal DNA Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Sequenom Laboratories
• Illumina, Inc.
• Ariosa Diagnostics
• Arup Laboratories
• The Fetal Medicine Centre
• Apollo Path labs

Market segment 5, the product can be split into

• Abnormal Chromosome Number Detection
• Gender Testing
• Paternally Inherited Disorder Detection
• Paternity testing
• Others

Market segment 2, split into

• Hospital
• Clinic Center

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cell-Free Fetal DNA Testing status, future forecast, growth opportunity, key market and key players.
• To present the Cell-Free Fetal DNA Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by , market and key regions.

In this study, the years considered to estimate the market size of Cell-Free Fetal DNA Testing are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, and , 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell-Free Fetal DNA Testing Revenue
1.4 Market Analysis
  1.4.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate 5: 2020 VS 2026
  1.4.2 Abnormal Chromosome Number Detection
  1.4.3 Gender Testing
  1.4.4 Paternally Inherited Disorder Detection
  1.4.5 Paternity testing
  1.4.6 Others
1.5 Market
  1.5.1 Global Cell-Free Fetal DNA Testing Market Share 2: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic Center
1.6 Coronavirus Disease 2019 (Covid-19): Cell-Free Fetal DNA Testing Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cell-Free Fetal DNA Testing Industry
    1.6.1.1 Cell-Free Fetal DNA Testing Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cell-Free Fetal DNA Testing Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cell-Free Fetal DNA Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cell-Free Fetal DNA Testing Market Perspective (2015-2026)
2.2 Cell-Free Fetal DNA Testing Growth Trends by Regions
  2.2.1 Cell-Free Fetal DNA Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cell-Free Fetal DNA Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Cell-Free Fetal DNA Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cell-Free Fetal DNA Testing Market Growth Strategy
  2.3.6 Primary Interviews with Key Cell-Free Fetal DNA Testing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cell-Free Fetal DNA Testing Players by Market Size
  3.1.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue (2015-2020)
  3.1.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cell-Free Fetal DNA Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell-Free Fetal DNA Testing Market Concentration Ratio
  3.2.1 Global Cell-Free Fetal DNA Testing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cell-Free Fetal DNA Testing Revenue in 2019
3.3 Cell-Free Fetal DNA Testing Key Players Head office and Area Served
3.4 Key Players Cell-Free Fetal DNA Testing Product Solution and Service
3.5 Date of Enter into Cell-Free Fetal DNA Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA 5 (2015-2026)

4.1 Global Cell-Free Fetal DNA Testing Historic Market Size 5 (2015-2020)
4.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size 5 (2021-2026)

5 CELL-FREE FETAL DNA TESTING BREAKDOWN DATA 2 (2015-2026)

5.1 Global Cell-Free Fetal DNA Testing Market Size 2 (2015-2020)
5.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size 2 (2021-2026)

6 NORTH AMERICA

6.1 North America Cell-Free Fetal DNA Testing Market Size (2015-2020)
6.2 Cell-Free Fetal DNA Testing Key Players in North America (2019-2020)
6.3 North America Cell-Free Fetal DNA Testing Market Size 5 (2015-2020)
6.4 North America Cell-Free Fetal DNA Testing Market Size 2 (2015-2020)

7 EUROPE

7.1 Europe Cell-Free Fetal DNA Testing Market Size (2015-2020)
7.2 Cell-Free Fetal DNA Testing Key Players in Europe (2019-2020)
7.3 Europe Cell-Free Fetal DNA Testing Market Size 5 (2015-2020)
7.4 Europe Cell-Free Fetal DNA Testing Market Size 2 (2015-2020)

8 CHINA

8.1 China Cell-Free Fetal DNA Testing Market Size (2015-2020)
8.2 Cell-Free Fetal DNA Testing Key Players in China (2019-2020)
8.3 China Cell-Free Fetal DNA Testing Market Size 5 (2015-2020)
8.4 China Cell-Free Fetal DNA Testing Market Size 2 (2015-2020)

9 JAPAN

9.1 Japan Cell-Free Fetal DNA Testing Market Size (2015-2020)
9.2 Cell-Free Fetal DNA Testing Key Players in Japan (2019-2020)
9.3 Japan Cell-Free Fetal DNA Testing Market Size 5 (2015-2020)
9.4 Japan Cell-Free Fetal DNA Testing Market Size 2 (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cell-Free Fetal DNA Testing Market Size (2015-2020)
10.2 Cell-Free Fetal DNA Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell-Free Fetal DNA Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Cell-Free Fetal DNA Testing Market Size by Application (2015-2020)

11 INDIA

11.1 India Cell-Free Fetal DNA Testing Market Size (2015-2020)
11.2 Cell-Free Fetal DNA Testing Key Players in India (2019-2020)
11.3 India Cell-Free Fetal DNA Testing Market Size by Type (2015-2020)
11.4 India Cell-Free Fetal DNA Testing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cell-Free Fetal DNA Testing Market Size (2015-2020)
12.2 Cell-Free Fetal DNA Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell-Free Fetal DNA Testing Market Size by Type (2015-2020)
12.4 Central & South America Cell-Free Fetal DNA Testing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Sequenom Laboratories
  13.1.1 Sequenom Laboratories Company Details
  13.1.2 Sequenom Laboratories Business Overview and Its Total Revenue
  13.1.3 Sequenom Laboratories Cell-Free Fetal DNA Testing Introduction
  13.1.4 Sequenom Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2015-2020))
  13.1.5 Sequenom Laboratories Recent Development
13.2 Illumina, Inc.
  13.2.1 Illumina, Inc. Company Details
  13.2.2 Illumina, Inc. Business Overview and Its Total Revenue
  13.2.3 Illumina, Inc. Cell-Free Fetal DNA Testing Introduction
  13.2.4 Illumina, Inc. Revenue in Cell-Free Fetal DNA Testing Business (2015-2020)
  13.2.5 Illumina, Inc. Recent Development
13.3 Ariosa Diagnostics
  13.3.1 Ariosa Diagnostics Company Details
  13.3.2 Ariosa Diagnostics Business Overview and Its Total Revenue
  13.3.3 Ariosa Diagnostics Cell-Free Fetal DNA Testing Introduction
  13.3.4 Ariosa Diagnostics Revenue in Cell-Free Fetal DNA Testing Business (2015-2020)
  13.3.5 Ariosa Diagnostics Recent Development
13.4 Arup Laboratories
  13.4.1 Arup Laboratories Company Details
  13.4.2 Arup Laboratories Business Overview and Its Total Revenue
  13.4.3 Arup Laboratories Cell-Free Fetal DNA Testing Introduction
  13.4.4 Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2015-2020)
  13.4.5 Arup Laboratories Recent Development
13.5 The Fetal Medicine Centre
  13.5.1 The Fetal Medicine Centre Company Details
  13.5.2 The Fetal Medicine Centre Business Overview and Its Total Revenue
  13.5.3 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Introduction
  13.5.4 The Fetal Medicine Centre Revenue in Cell-Free Fetal DNA Testing Business (2015-2020)
  13.5.5 The Fetal Medicine Centre Recent Development
13.6 Apollo Path labs
  13.6.1 Apollo Path labs Company Details
  13.6.2 Apollo Path labs Business Overview and Its Total Revenue
  13.6.3 Apollo Path labs Cell-Free Fetal DNA Testing Introduction
  13.6.4 Apollo Path labs Revenue in Cell-Free Fetal DNA Testing Business (2015-2020)
  13.6.5 Apollo Path labs Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cell-Free Fetal DNA Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Cell-Free Fetal DNA Testing Revenue
Table 3. Ranking of Global Top Cell-Free Fetal DNA Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell-Free Fetal DNA Testing Market Size Growth Rate 5 (US$ Million): 2020 VS 2026
Table 5. Key Players of Abnormal Chromosome Number Detection
Table 6. Key Players of Gender Testing
Table 7. Key Players of Paternally Inherited Disorder Detection
Table 8. Key Players of Paternity testing
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Cell-Free Fetal DNA Testing Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Cell-Free Fetal DNA Testing Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Cell-Free Fetal DNA Testing Players to Combat Covid-19 Impact
Table 15. Global Cell-Free Fetal DNA Testing Market Size Growth 2 (US$ Million): 2020 VS 2026
Table 16. Global Cell-Free Fetal DNA Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Cell-Free Fetal DNA Testing Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Cell-Free Fetal DNA Testing Market Share by Regions (2015-2020)
Table 19. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Cell-Free Fetal DNA Testing Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Cell-Free Fetal DNA Testing Market Growth Strategy
Table 25. Main Points Interviewed from Key Cell-Free Fetal DNA Testing Players
Table 26. Global Cell-Free Fetal DNA Testing Revenue by Players (2015-2020) (Million US$)
Table 27. Global Cell-Free Fetal DNA Testing Market Share by Players (2015-2020)
Table 28. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free Fetal DNA Testing as of 2019)
Table 29. Global Cell-Free Fetal DNA Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Cell-Free Fetal DNA Testing Product Solution and Service
Table 32. Date of Enter into Cell-Free Fetal DNA Testing Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 35. Global Cell-Free Fetal DNA Testing Market Size Share 5 (2015-2020)
Table 36. Global Cell-Free Fetal DNA Testing Revenue Market Share 5 (2021-2026)
Table 37. Global Cell-Free Fetal DNA Testing Market Size Share 2 (2015-2020)
Table 38. Global Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 39. Global Cell-Free Fetal DNA Testing Market Size Share 2 (2021-2026)
Table 40. North America Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 42. North America Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 43. North America Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 44. North America Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 45. North America Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 46. Europe Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 48. Europe Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 49. Europe Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 50. Europe Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 51. Europe Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 52. China Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 53. China Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 54. China Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 55. China Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 56. China Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 57. China Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 58. Japan Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 60. Japan Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 61. Japan Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 62. Japan Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 63. Japan Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 64. Southeast Asia Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 66. Southeast Asia Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 67. Southeast Asia Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 68. Southeast Asia Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 69. Southeast Asia Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 70. India Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 71. India Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 72. India Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 73. India Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 74. India Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 75. India Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 76. Central & South America Key Players Cell-Free Fetal DNA Testing Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Cell-Free Fetal DNA Testing Market Share (2019-2020)
Table 78. Central & South America Cell-Free Fetal DNA Testing Market Size 5 (2015-2020) (Million US$)
Table 79. Central & South America Cell-Free Fetal DNA Testing Market Share 5 (2015-2020)
Table 80. Central & South America Cell-Free Fetal DNA Testing Market Size 2 (2015-2020) (Million US$)
Table 81. Central & South America Cell-Free Fetal DNA Testing Market Share 2 (2015-2020)
Table 82. Sequenom Laboratories Company Details
Table 83. Sequenom Laboratories Business Overview
Table 84. Sequenom Laboratories Product
Table 85. Sequenom Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 86. Sequenom Laboratories Recent Development
Table 87. Illumina, Inc. Company Details
Table 88. Illumina, Inc. Business Overview
Table 89. Illumina, Inc. Product
Table 90. Illumina, Inc. Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 91. Illumina, Inc. Recent Development
Table 92. Ariosa Diagnostics Company Details
Table 93. Ariosa Diagnostics Business Overview
Table 94. Ariosa Diagnostics Product
Table 95. Ariosa Diagnostics Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 96. Ariosa Diagnostics Recent Development
Table 97. Arup Laboratories Company Details
Table 98. Arup Laboratories Business Overview
Table 99. Arup Laboratories Product
Table 100. Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 101. Arup Laboratories Recent Development
Table 102. The Fetal Medicine Centre Company Details
Table 103. The Fetal Medicine Centre Business Overview
Table 104. The Fetal Medicine Centre Product
Table 105. The Fetal Medicine Centre Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 106. The Fetal Medicine Centre Recent Development
Table 107. Apollo Path labs Company Details
Table 108. Apollo Path labs Business Overview
Table 109. Apollo Path labs Product
Table 110. Apollo Path labs Revenue in Cell-Free Fetal DNA Testing Business (2015-2020) (Million US$)
Table 111. Apollo Path labs Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cell-Free Fetal DNA Testing Market Share 5: 2020 VS 2026
Figure 2. Abnormal Chromosome Number Detection Features
Figure 3. Gender Testing Features
Figure 4. Paternally Inherited Disorder Detection Features
Figure 5. Paternity testing Features
Figure 6. Others Features
Figure 7. Global Cell-Free Fetal DNA Testing Market Share 2: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Center Case Studies
Figure 10. Cell-Free Fetal DNA Testing Report Years Considered
Figure 11. Global Cell-Free Fetal DNA Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell-Free Fetal DNA Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell-Free Fetal DNA Testing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell-Free Fetal DNA Testing Market Share by Players in 2019
Figure 16. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Free Fetal DNA Testing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell-Free Fetal DNA Testing Revenue in 2019
Figure 18. North America Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell-Free Fetal DNA Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Sequenom Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sequenom Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 27. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Illumina, Inc. Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 29. Ariosa Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Ariosa Diagnostics Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 31. Arup Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Arup Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 33. The Fetal Medicine Centre Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. The Fetal Medicine Centre Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 35. Apollo Path labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Apollo Path labs Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed